Published in Circ Cardiovasc Interv on March 02, 2010
A Novel Tram Stent Method in the Treatment of Coronary Bifurcation Lesions - Finite Element Study. PLoS One (2016) 0.75
Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach. Case Rep Cardiol (2016) 0.75
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40
Postconditioning the human heart. Circulation (2005) 4.35
Rho kinases in cardiovascular physiology and pathophysiology. Circ Res (2006) 2.97
Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2012) 2.68
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol (2010) 2.54
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med (2010) 1.84
Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res (2003) 1.68
Long-term benefit of postconditioning. Circulation (2008) 1.65
Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol (2013) 1.59
Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol (2008) 1.58
Adhesion and osteogenic differentiation of human mesenchymal stem cells on titanium nanopores. Eur Cell Mater (2011) 1.52
How reliable are 40 MHz IVUS and 64-slice MDCT in characterizing coronary plaque composition? An ex vivo study with histopathological comparison. Int J Cardiovasc Imaging (2010) 1.50
The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation. J Biol Chem (2013) 1.49
Influence of residual stress/strain on the biomechanical stability of vulnerable coronary plaques: potential impact for evaluating the risk of plaque rupture. Am J Physiol Heart Circ Physiol (2007) 1.38
Useful side handle for holding needle during ultrasound-guided regional anesthesia. Reg Anesth Pain Med (2009) 1.38
RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J Biol Chem (2003) 1.35
Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. J Cell Sci (2004) 1.33
RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med (2009) 1.28
Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem (2006) 1.27
Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res (2007) 1.26
Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone (2005) 1.25
Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ Res (2005) 1.24
Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol (2005) 1.24
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
The role of Rho protein signaling in hypertension. Nat Rev Cardiol (2010) 1.23
Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology (2003) 1.21
Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation (2003) 1.20
Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS One (2012) 1.14
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process. Cancer Res (2010) 1.10
Proprotein convertase subtilisin/kexin type 9 inhibition. Curr Opin Lipidol (2012) 1.08
Differential dependence on Beclin 1 for the regulation of pro-survival autophagy by Bcl-2 and Bcl-xL in HCT116 colorectal cancer cells. PLoS One (2010) 1.06
Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation. Circ Res (2008) 1.05
Shear stress regulates endothelial microparticle release. Circ Res (2013) 1.05
RhoE Is required for keratinocyte differentiation and stratification. Mol Biol Cell (2008) 1.05
Vulnerable atherosclerotic plaque elasticity reconstruction based on a segmentation-driven optimization procedure using strain measurements: theoretical framework. IEEE Trans Med Imaging (2009) 1.05
RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc Res (2006) 1.04
Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc Res (2006) 1.04
Novel biomaterials for bisphosphonate delivery. Biomaterials (2005) 1.04
Adapting the Lagrangian speckle model estimator for endovascular elastography: theory and validation with simulated radio-frequency data. J Acoust Soc Am (2004) 1.04
Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Liver Transpl (2010) 1.04
Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am J Physiol Cell Physiol (2009) 1.03
Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials (2005) 1.00
Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound. Circulation (2004) 0.97
Small G proteins in the cardiovascular system: physiological and pathological aspects. Physiol Rev (2013) 0.97
Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis (2011) 0.96
WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice. Hypertension (2011) 0.95
Which diameter and angle rule provides optimal flow patterns in a coronary bifurcation? J Biomech (2012) 0.95
On the potential of the lagrangian estimator for endovascular ultrasound elastography: in vivo human coronary artery study. Ultrasound Med Biol (2007) 0.95
The safety and efficacy of an injectable bone substitute in dental sockets demonstrated in a human clinical trial. Biomaterials (2007) 0.94
Regulation of Rho proteins by phosphorylation in the cardiovascular system. Trends Cardiovasc Med (2006) 0.94
Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats. Circulation (2010) 0.93
Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J Immunol (2007) 0.91
RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration. Mol Cell Biol (2010) 0.90
Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides (2004) 0.90
Behaviour of mesenchymal stem cells, fibroblasts and osteoblasts on smooth surfaces. Acta Biomater (2010) 0.90
AMPK alpha 1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol. Arterioscler Thromb Vasc Biol (2011) 0.90
Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites. J Mater Sci Mater Med (2007) 0.89
Rho exchange factors in the cardiovascular system. Curr Opin Pharmacol (2008) 0.89
Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite. J Mater Sci Mater Med (2007) 0.88
Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification. Lab Invest (2011) 0.87
On the potential of a new IVUS elasticity modulus imaging approach for detecting vulnerable atherosclerotic coronary plaques: in vitro vessel phantom study. Phys Med Biol (2010) 0.87
Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol (2009) 0.86
RhoA and resistance artery remodeling. Am J Physiol Heart Circ Physiol (2005) 0.86
The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration. Cardiovasc Res (2009) 0.86
Calcium phosphate scaffold and bone marrow for bone reconstruction in irradiated area: a dog study. Bone (2005) 0.85
Endovascular treatment of acute complications associated with aortic dissection: midterm results from a multicenter study. J Endovasc Ther (2003) 0.85
Primary PCI with or without Thrombectomy. N Engl J Med (2015) 0.85
Is arterial wall-strain stiffening an additional process responsible for atherosclerosis in coronary bifurcations?: an in vivo study based on dynamic CT and MRI. Am J Physiol Heart Circ Physiol (2011) 0.85
Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycin. J Vasc Res (2004) 0.85
Alveolar bone regeneration for immediate implant placement using an injectable bone substitute: an experimental study in dogs. J Periodontol (2004) 0.84
Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. Cytokine (2012) 0.84
Acute compartment syndrome of the thigh secondary to isolated common femoral vessel injury: an unusual etiology. Ann Vasc Surg (2013) 0.84
MBCP biphasic calcium phosphate granules and tissucol fibrin sealant in rabbit femoral defects: the effect of fibrin on bone ingrowth. J Mater Sci Mater Med (2005) 0.84
Physico-chemical-mechanical and in vitro biological properties of calcium phosphate cements with doped amorphous calcium phosphates. Biomaterials (2006) 0.84
Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status. J Nutr Biochem (2013) 0.84
Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis. Eur J Nutr (2014) 0.83
Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Circ Res (2003) 0.83
Regulation of Rho signaling pathways in interleukin-2-stimulated human T-lymphocytes. FASEB J (2005) 0.83